Celgene files suit against Par Pharmaceutical over six patents related to a pharmaceutical unit dosage comprising from about 1 to about 50 milligrams of D-threo-methylphenidate. 5/27, District of New Jersey, 2:2011cv03094.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.
